Christine Jenkins—global advocate for asthma and COPD

Abstract

Speaking to The Lancet Respiratory Medicine on her first overseas trip since COVID-19 arrived, Christine Jenkins reflects that “one of the few good things that COVID has done is to focus people's attention on how important lung health is for our overall health”. As Chair of the Lung Foundation Australia over the past 6 years, she has been actively raising the profile of lung diseases. For four decades, she has been a clinician-researcher aiming to improve outcomes and care for people with asthma and COPD, and currently heads the Respiratory Group at the George Institute, based at the University of New South Wales (UNSW), Sydney, Australia.